Anaphylactoid reactions to i.v. substances.
D000530:Alfaxalone Alfadolone Mixture / Q000009:adverse effects; D000707:Anaphylaxis / Q000139:chemically induced* / Q000276:immunology / Q000628:therapy; D003165:Complement System Proteins / Q000276:immunology; D003287:Contrast Media / Q000009:adverse effects; D004342:Drug Hypersensitivity / Q000209:etiology* / Q000276:immunology / Q000628:therapy; D006801:Humans; D006993:Hypnotics and Sedatives / Q000009:adverse effects; D007275:Injections, Intravenous; D010952:Plasma Substitutes / Q000009:adverse effects
D003287:Contrast Media; D006993:Hypnotics and Sedatives; D010952:Plasma Substitutes; D000530:Alfaxalone Alfadolone Mixture; D003165:Complement System Proteins